Edition:
India

Solasia Pharma KK (4597.T)

4597.T on Tokyo Stock Exchange

171JPY
18 Jul 2019
Change (% chg)

¥-2 (-1.16%)
Prev Close
¥173
Open
¥171
Day's High
¥173
Day's Low
¥168
Volume
547,900
Avg. Vol
1,650,305
52-wk High
¥354
52-wk Low
¥118

Latest Key Developments (Source: Significant Developments)

Solasia Pharma to issue new shares to raise up to 4.34 bln yen
Tuesday, 28 Aug 2018 

Aug 28 (Reuters) - Solasia Pharma KK <4597.T>:Says it will issue 14.8 million shares via public offering and 2.2 million shares via private placement .Says it aims to raise up to 4.34 billion yen in total, to invest in clinical trials .  Full Article

Solasia Pharma says termination of clinical trials phase 1 of SP-04
Friday, 9 Feb 2018 

Feb 9 (Reuters) - Solasia Pharma KK <4597.T>:Says it announces termination of SP-04 clinical trials phase 1, for treatment of peripheral nerves disability .  Full Article

Pledpharma and Solasia enter license agreement on Pledox in Asia
Monday, 20 Nov 2017 

Nov 20 (Reuters) - PLEDPHARMA AB (PUBL) :PLEDPHARMA AND SOLASIA ENTER LICENSE AGREEMENT TO DEVELOP AND COMMERCIALIZE PLEDOX® IN ASIA .PLEDPHARMA AB (PUBL) - ‍SOLASIA WILL PAY UPFRONT, DEVELOPMENT, REGULATORY AND SALES MILESTONES OF UP TO ABOUT USD 83 MILLION​.PLEDPHARMA AB (PUBL) - ‍SOLASIA WILL PAY INDUSTRY STANDARD ROYALTY RATES ON SALES​.PLEDPHARMA AB (PUBL) - ‍WILL ALSO FULLY FINANCE AN EXPANSION OF PHASE III PROGRAM FOR PLEDOX​.‍TOTAL VALUE OF UPFRONT AND MILESTONE PAYMENTS IS UP TO JPY 9.3 BILLION​.‍PHASE III STUDIES ANTICIPATED TO BE INITIATED END OF 2017 WITH TOP LINE RESULTS EXPECTED IN 2020​.  Full Article

Solasia Pharma to sign distributorship agreement with ITOCHU
Wednesday, 13 Sep 2017 

Sept 13(Reuters) - Solasia Pharma KK <4597.T>:Says it plans to sign a distributorship agreement with ITOCHU Corp <<<8001.T>>>, regarding sales of the company's products in China (except Hong Kong and Macau ).  Full Article